Don’t forget ibrutinib combined with a Heat Shock Protein Inhibitor (SNX-5422). There is a clinical trial going on now. (ID#NCT02973399).
Also, Cart T-Cell Therapy combined with ibrutinib.
If Car T-Cell Therapy with ROR1 as a target is effective, I would like to see a subsequent study combing it with Ibrutinib.